Janssen-Cilag (Janssen), a subsidiary of Johnson & Johnson pharmaceutical firm, has submitted marketing authorization application (MAA) to the European Medicines Agency (EMA) for the approval of once daily oral drug ibrutinib for the ...
Tags: Blood Cancer Medicine, Medicine
Bend Research, part of Capsugel’s Dosage Form Solutions business unit, announced the addition of Capsugel’s Xcelodose precision powder-filling technology to its drug development process. This patented micro-dosing technology ...
The coding technology specialist gauged the opinions of pharmaceutical manufacturers, industry bodies and thought leaders on the challenges of meeting the directive. The survey highlighted a broad range of opinion around subjects spanning ...
Pulmatrix has released positive results from initial stage of Phase IB clinical trial of a bronchodilator therapy PUR0200 for patients with chronic obstructive pulmonary disease (COPD). The company said PUR0200 is the first small molecule ...
The medicinal products market is changing. Sensitive biopharmaceuticals require more robust packages. Falsification has to be prevented with special seals and codes. And additional package features are necessary so that patients can safely ...
British drug maker GlaxoSmithKline (GSK) has received positive opinion from the European Medicines Agency (EMA's) Committee for Medicinal Products for Human Use (CHMP) for additional indication for Synflorix, a pediatric pneumococcal ...
Tags: drug, Pneumonia Indication
Antares Pharma, a provider of self-injection drug delivery technology, has received a US Patent, entitled 'Prefilled Syringe Jet Injector', which will help in protecting its auto injector technology and product pipeline including the VIBEX ...
Transparency Market Research is Published new Market Report “Glass Packaging Market for Food and Beverage, Pharmaceuticals, Beer and Other Alcoholic Beverages - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 ...
Allergan has received a positive opinion for its Vistabel (botulinum toxin type A) from France's National Security Agency of Medicines and Health Products (ANSM) to treat moderate to severe crow's feet lines in adult patients. The ...
Tags: Allergan, Crow's Feet Lines
The US FDA's Antiviral Drugs Advisory Committee has recommended approval for Medivir's investigational protease inhibitor simeprevir (TMC435) 150mg capsules for the treatment of genotype 1 chronic hepatitis C in adult patients with ...
Tags: Medivir, Hepatitis C Patients
Belgian biotechnology firm Cardio3 BioSciences has secured approval from the Italian Medicines Agency (Agenzia Italiana del Farmaco) to start its congestive heart failure cardiopoietic regenerative therapy (CHART-1) European Phase III trial ...
Tags: Cardio3 Biosciences, C-Cure Drug
Eli Lilly and Company has received priority review status from the US Food and Drug Administration (FDA) for its ramucirumab (IMC-1121B) as a single-agent treatment for advanced gastric cancer following disease progression after initial ...
Tags: Cancer Drug, FDA Priority
Business Secretary Vince Cable and Business Minister Michael Fallon will today meet business leaders – including Johnson Matthey and Sabic - to take forward the industry-led strategy which sets a vision of 50% growth of the sector by ...
Tags: Chemical Sector, Chemicals
Netherland-based injectable drug delivery products producer InnoCore Pharmaceuticals has signed an exclusive license and collaboration agreement with Allergan (AGN), to develop new medicines for ophthalmic diseases. The deal will see the ...
Tags: injectable drug, Innocore
US-based iCeutica announced that its partner Iroko Pharmaceuticals has received the US Food and Drug Administration (FDA) approval to market ZORVOLEX (diclofenac) capsules, a non-steroidal anti-inflammatory drug (NSAID) that utilizes ...